Characterization and Pathogenic Speculation of Xerostomia Associated with COVID-19: A Narrative Review.
Reads0
Chats0
TLDR
Xerostomia associated with coronavirus disease 2019 (COVID-19) was characterized and its possible pathogenesis was speculated by a narrative literature review as mentioned in this paper, however, xerostomsia remains poorly recognized compared with taste dysfunction.Abstract:
Patients with coronavirus disease 2019 (COVID-19) have become known to present with different oral symptoms. However, xerostomia remains poorly recognized compared with taste dysfunction. For better understanding of COVID-19 symptomatology, xerostomia associated withCOVID-19 was characterized and its possible pathogenesis was speculated by a narrative literature review. Scientific articles were retrieved by searching PubMed, LitCovid, ProQuest, Google Scholar, medRxiv and bioRxiv from 1 April 2020 with a cutoff date of 30 September 2021. Results of the literature search indicated that xerostomia is one of prevalent and persistent oral symptoms associated with COVID-19. In contrast to taste dysfunction, the prevalence and persistence of xerostomia do not necessarily depend on ethnicity, age, gender and disease severity of patients. COVID-19 xerostomia is pathogenically related to viral cellular entry-relevant protein expression, renin-angiotensin system disturbance, salivary gland inflammation, zinc deficiency, cranial neuropathy, intercurrent taste dysfunction, comorbidities and medications. Despite a close association with COVID-19, xerostomia, dry mouth and hyposalivation tend to be overlooked unlike ageusia, dysgeusia and hypogeusia. Although mouth dryness per se is not life-threating, it has an impact on the oral health-related quality of life. More attention should be paid to xerostomia in COVID-19 patients and survivors.read more
Citations
More filters
Journal ArticleDOI
Oral Pathology in COVID-19 and SARS-CoV-2 Infection—Molecular Aspects
TL;DR: The review also presents information about the factors modifying SARS-CoV-2 infection potential and possible local pharmacotherapeutic interventions, which may confine SEMS coronavirus entry and transmission in the oral cavity.
Journal ArticleDOI
Gustatory and Saliva Secretory Dysfunctions in COVID-19 Patients with Zinc Deficiency
TL;DR: It is indicated that gustatory dysfunction and saliva secretory dysfunction are prevalent in COVID-19 patients and both dysfunctions persist after recovery from the disease, suggesting the pathogenic mechanism common to these cooccurring symptoms.
Posted ContentDOI
Evidence of a Sjögren’s disease-like phenotype following COVID-19
Yiran Shen,Alexandria Voigt,L. Goranova,Mehdi Abed,David E. Kleiner,José Maldonado,Margaret Beach,Eileen Pelayo,John A. Chiorini,William F. Craft,David A. Ostrov,Vijay Ramiya,Sukesh Sukumaran,Apichai Tuanyok,Blake M. Warner,Cuong Q. Nguyen +15 more
TL;DR: This study shows a direct association between SARS-CoV-2 and SjD and found monoclonal antibodies produced in recovered patients can both block ACE2/spike interaction and recognize nuclear antigens.
Journal ArticleDOI
The Oral Cavity Potentially Serving as a Reservoir for SARS-CoV-2 but Not Necessarily Facilitating the Spread of COVID-19 in Dental Practice
TL;DR: In this paper , the authors discuss the possibility that the oral cavity facilitates the spread of coronavirus disease 2019 (COVID-19) in dental practice, and they find that SARS-CoV-2 inhabits periodontal pocket, gingival sulcus, and dental caries lesion.
Journal ArticleDOI
Loss of Sour Taste Is the Striking Feature among Four Basic Taste Qualities in Tunisian COVID-19 Patients
Inchirah Karmous,Amira Sayed Khan,Imen Sahnoun,Rym Ben Othman,Houda Ben Jemaa,Faten Mahjoub,A. Gamoudi,L. Douik El Gharbi,T. Mestiri,N. Khan,Henda Jamoussi +10 more
TL;DR: In this article , the authors conducted an objective assessment of four basic taste qualities by conducting tasting sessions that allowed detection thresholds in COVID-19 Tunisian patients and to study their associations with inflammation.
References
More filters
Journal ArticleDOI
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported.
Journal ArticleDOI
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann,Hannah Kleine-Weber,Simon Schroeder,Nadine Krüger,Tanja Herrler,Sandra Erichsen,Tobias S. Schiergens,Georg Herrler,Nai Huei Wu,Andreas Nitsche,Marcel A. Müller,Christian Drosten,Christian Drosten,Stefan Pöhlmann +13 more
TL;DR: It is demonstrated that SARS-CoV-2 uses the SARS -CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming, and it is shown that the sera from convalescent SARS patients cross-neutralized Sars-2-S-driven entry.
Journal ArticleDOI
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
Dorothea Bestle,Miriam Ruth Heindl,Hannah Limburg,Thuy Van Lam van,Oliver Pilgram,Hong M. Moulton,David A. Stein,Kornelia Hardes,Kornelia Hardes,Markus Eickmann,Olga Dolnik,Cornelius Rohde,Hans-Dieter Klenk,Wolfgang Garten,Torsten Steinmetzer,Eva Böttcher-Friebertshäuser +15 more
TL;DR: It is shown that S can be cleaved by the proprotein convertase furin at the S1/S2 site and the transmembrane serine protease 2 (TMPRSS2) at theS2′ site, and this approach has considerable therapeutic potential for treatment of COVID-19.
Journal ArticleDOI
SARS-CoV-2 infection of the oral cavity and saliva.
Ni Huang,Paola Perez,Takafumi Kato,Yu Mikami,Kenichi Okuda,Rodney C. Gilmore,Cecilia Domínguez Conde,Billel Gasmi,Sydney Stein,Margaret Beach,Eileen Pelayo,José O. Maldonado,Bernard A. P. Lafont,Shyh-Ing Jang,Nadia Nasir,Ricardo J. Padilla,Valerie A. Murrah,Robert Maile,William Lovell,Shannon M. Wallet,Natalie M. Bowman,Suzanne L Meinig,Matthew C. Wolfgang,Saibyasachi N. Choudhury,Mark Novotny,Brian D. Aevermann,Richard H. Scheuermann,Gabrielle Cannon,Carlton W Anderson,Rhianna E. Lee,Julie T. Marchesan,Mandy Bush,Marcelo Freire,Adam J. Kimple,Daniel Herr,Joseph Rabin,Alison Grazioli,Sanchita Das,Benjamin N French,Thomas Pranzatelli,John A. Chiorini,David E. Kleiner,Stefania Pittaluga,Stephen M. Hewitt,Peter D. Burbelo,Daniel S. Chertow,Karen M. Frank,Janice Lee,Richard C. Boucher,Sarah A. Teichmann +49 more
TL;DR: In this article, the authors generated and analyzed two single-cell RNA sequencing datasets of the human minor salivary glands and gingiva (9 samples, 13,824 cells), identifying 50 cell clusters.
Journal ArticleDOI
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
TL;DR: In this paper, the authors reviewed the existing literature and knowledge of ACE2 in COVID-19 setting and focused on its pathophysiologic involvement in disease progression, clinical outcomes, and therapeutic potential.